FindMyKOL

William Rollefson, MD

Basic profile

Arkansas Heart Hospital

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionLittle Rock, AR · South CentralSpecialtyCardiovascular DiseaseFocusCardiology
Active KOLFindMyKOL type: RegionalLatest publication2026Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

William Rollefson is a Cardiology physician affiliated with Arkansas Heart Hospital. OpenAlex indexes 29 publications with 390 citations (h-index 9).

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
29publications

Publications indexed by OpenAlex. Counts exclude supporting files.

390citations

Citations across these publications.

9h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
20companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Industry payments

20 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Abbott
    Program year202531 paymentsResearch
    $98,344
  • Endologix LLC
    Program year20251 payment
    $600
  • Abbott Laboratories
    Program year202517 payments
    $512
All 44 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    74.8%
    Beta blocker20.2%
    Metoprolol Succinate57%Carvedilol14%Metoprolol Tartrate14%Atenolol6%Sotalol4%Bisoprolol Fumarate2%Bisoprolol-Hydrochlorothiazide1%Propranolol Hcl1%
    Part D<11 patients
    Statin11.9%
    Atorvastatin Calcium52%Pravastatin Sodium18%Rosuvastatin Calcium16%Simvastatin13%Lovastatin1%
    Part D<11 patients

    + 19 more classes in this area

  • Blood & clotting

    20.1%
    P2Y12 inhibitor12.3%
    Clopidogrel91%Prasugrel Hcl9%
    Part D≥211 patients
    Factor Xa inhibitor6.5%
    Eliquis77%Xarelto23%
    Part D≥78 patients

    + 1 more class in this area

  • Metabolism & gastrointestinal

    5.1%
    Potassium supplement3%
    Potassium Chloride100%
    Part D≥51 patients
    Proton pump inhibitor1.9%
    Pantoprazole Sodium61%Omeprazole39%
    Part D≥19 patients

    + 1 more class in this area

Where care is delivered (Part B)65.2% facility · 34.8% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”